Company
ELVN · CIK 0001672619
Acquisition (code M) of 5,000 shares at $2.48 per share.
Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code M
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001701247-26-000013 · filed 2026-09-21 · View filing →
Sale of 2,916 shares at $50.0312 per share.
Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001701247-26-000013 · filed 2026-09-21 · View filing →
Sale of 1,844 shares at $50.7089 per share.
Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001701247-26-000013 · filed 2026-09-21 · View filing →
Sale of 240 shares at $51.482 per share.
Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001701247-26-000013 · filed 2026-09-21 · View filing →
Acquisition (code M) of 3,982 shares at $14.85 per share.
Reporting Person Hohl Benjamin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code M
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001882764-26-000008 · filed 2026-09-21 · View filing →
Sale of 3,535 shares at $50.0286 per share.
Reporting Person Hohl Benjamin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001882764-26-000008 · filed 2026-09-21 · View filing →
Sale of 2,194 shares at $50.7158 per share.
Reporting Person Hohl Benjamin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001882764-26-000008 · filed 2026-09-21 · View filing →
Sale of 289 shares at $51.4929 per share.
Reporting Person Hohl Benjamin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S
Traded Sep 17, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001882764-26-000008 · filed 2026-09-21 · View filing →
Acquisition (code M) of 5,000 shares at $2.48 per share.
Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code M
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001701247-26-000012 · filed 2026-08-19 · View filing →
Sale of 3,900 shares at $58.3717 per share.
Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001701247-26-000012 · filed 2026-08-19 · View filing →
Sale of 1,100 shares at $59.3465 per share.
Reporting Person Collins Helen Louise · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001701247-26-000012 · filed 2026-08-19 · View filing →
Sale of 4,630 shares at $58.3517 per share.
Reporting Person Hohl Benjamin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001882764-26-000007 · filed 2026-08-19 · View filing →
Sale of 1,388 shares at $59.3536 per share.
Reporting Person Hohl Benjamin · Officer Title CHIEF FINANCIAL OFFICER · Transaction Code S
Traded Aug 17, 2026 · Disclosed Aug 19, 2026
Source: SEC Form 4 · 0001882764-26-000007 · filed 2026-08-19 · View filing →